Expanded Access of Fostamatinib in Patients With Persistent or Chronic

Clinical Trial Description

The purpose of the program is to provide Fostamatinib in an Expanded Access setting to subjects who meet the selection criteria. ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01255332` - Helicobacter Pylori Immune Thrombocytopenic Purpura	Phase 2
Completed	`NCT02077192` - Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)	Phase 3
Completed	`NCT01719692` - Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia	N/A
Completed	`NCT01621204` - A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients	Phase 3
Completed	`NCT01730352` - Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients	Phase 2/Phase 3
Completed	`NCT01713855` - Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura	N/A
Not yet recruiting	`NCT05093257` - Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura
Completed	`NCT01390649` - A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)	Phase 4
Completed	`NCT01672151` - Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia	N/A
Completed	`NCT01439321` - Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim	N/A
Completed	`NCT00774202` - Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP	Phase 2/Phase 3
Completed	`NCT02273960` - Study to Evaluate Safety and Efficacy in Adult Subjects With ITP	Phase 1/Phase 2
Not yet recruiting	`NCT05585944` - " Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "	N/A
Recruiting	`NCT03177629` - H. Pylori Eradication for Moderate ITP	Phase 3
Not yet recruiting	`NCT05835050` - Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital	N/A
Active, not recruiting	`NCT03395210` - A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)	Phase 2
Completed	`NCT00621894` - Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation	Phase 2
Completed	`NCT01652599` - Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT	Phase 2
Completed	`NCT00426270` - Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults	Phase 3
Completed	`NCT02085993` - Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training	N/A

NCT number	NCT03363334
Study type	Expanded Access
Source	Rigel Pharmaceuticals
Contact
Status	No longer available
Phase

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms